Tempest Therapeutics, Inc.
TPST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001544227
No open-market purchases or sales by Tempest Therapeutics, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.44M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Tempest Therapeutics, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 13 | 17 | +4 |
| Shares | 3.07M | 3.11M | +42.2K (+1.4%) |
| Value | $3.54M | $7.21M | +$3.68M (+104.0%) |
New holders (5)
Institutions that held Tempest Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 16,797 | $39.0K | 0.00% |
| Northern Trust Corp | 13,553 | $31.4K | 0.00% |
| Susquehanna International Group, LLP | 11,087 | $25.7K | 0.00% |
| JPMorgan Chase & Co | 313 | $1.00K | 0.00% |
| Advisor Group Holdings, Inc. | 100 | $232 | 0.00% |
Sold out (1)
Institutions that held Tempest Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Franklin Resources Inc | 11,308 | $13.1K |